We are live on ! Find out more
BLAM

Bourne Lent Asset Management Portfolio holdings

AUM $289M
1-Year Est. Return 30.86%
This Fund
S&P 500
This Quarter Est. Return
+3.89%
1 Year Est. Return
+30.86%
3 Year Est. Return
+76.09%
5 Year Est. Return
+95.46%
10 Year Est. Return
+670.42%
AUM
$313M
AUM Growth
+$9.81M
Cap. Flow
+$1.72M
Cap. Flow %
0.55%
Top 10 Hldgs %
73.71%
Holding
63
New
3
Increased
12
Reduced
9
Closed
2

Top Buys

Rank Stock Value
1
NVTA
Invitae Corporation
NVTA
+$3.06M
2
NTR icon
Nutrien
NTR
+$332K
3
T icon
AT&T
T
+$285K
4
JPM icon
JPMorgan Chase
JPM
+$216K
5
XOM icon
ExxonMobil
XOM
+$192K

Top Sells

Rank Stock Value
1
IDXX icon
Idexx Laboratories
IDXX
+$752K
2
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$665K
3
BMY icon
Bristol-Myers Squibb
BMY
+$365K
4
BNY
Bank of New York Mellon
BNY
+$297K
5
ADBE icon
Adobe
ADBE
+$257K

Sector Composition

Rank Sector Weight
1 Technology 38.53%
2 Healthcare 33.65%
3 Communication Services 10.74%
4 Consumer Discretionary 6.17%
5 Financials 3.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LHX icon
26
L3Harris
LHX
$53.4B
$1.96M 0.63%
9,690
+200
+2% +$37.5K
V icon
27
Visa
V
$677B
$1.84M 0.59%
8,700
+150
+2% +$31.6K
MA icon
28
Mastercard
MA
$493B
$1.78M 0.57%
4,998
– –
BRK.A icon
29
Berkshire Hathaway Class A
BRK.A
$1.12T
$1.54M 0.49%
4
– –
PFE icon
30
Pfizer
PFE
$153B
$1.4M 0.45%
38,679
+700
+2% +$24.9K
AMGN icon
31
Amgen
AMGN
$222B
$1.28M 0.41%
5,137
– –
ILMN icon
32
Illumina
ILMN
$28.4B
$1.23M 0.39%
3,290
– –
PEG icon
33
Public Service Enterprise Group
PEG
$37.7B
$910K 0.29%
15,122
– –
PEP icon
34
PepsiCo
PEP
$190B
$796K 0.25%
5,625
– –
LLY icon
35
Eli Lilly
LLY
$1.06T
$761K 0.24%
4,076
– –
INTC icon
36
Intel
INTC
$513B
$735K 0.23%
11,490
– –
BSX icon
37
Boston Scientific
BSX
$71.5B
$685K 0.22%
17,719
– –
LOW icon
38
Lowe's Companies
LOW
$125B
$666K 0.21%
3,500
– –
VZ icon
39
Verizon
VZ
$196B
$623K 0.2%
10,719
+211
+2% +$11.9K
MCHP icon
40
Microchip Technology
MCHP
$46B
$615K 0.2%
7,930
– –
VAR
41
DELISTED
Varian Medical Systems, Inc.
VAR
$528K 0.17%
2,990
– –
GILD icon
42
Gilead Sciences
GILD
$165B
$495K 0.16%
7,655
+200
+3% +$12.9K
PG icon
43
Procter & Gamble
PG
$339B
$473K 0.15%
3,491
– –
MRK icon
44
Merck
MRK
$318B
$460K 0.15%
6,253
– –
HD icon
45
Home Depot
HD
$355B
$443K 0.14%
1,450
– –
CTSH icon
46
Cognizant
CTSH
$26B
$391K 0.12%
5,000
– –
CNP icon
47
CenterPoint Energy
CNP
$26.8B
$384K 0.12%
16,966
– –
BA icon
48
Boeing
BA
$185B
$364K 0.12%
1,428
– –
ABT icon
49
Abbott
ABT
$187B
$308K 0.1%
2,568
– –
INTU icon
50
Intuit
INTU
$89B
$306K 0.1%
799
+1
+0.1% +$385
1
2
3

Similar funds

PIA
PineBridge Investments Asia Hong Kong $289M AUM
CCC
Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return
GIM
Goodlander Investment Management Dallas, Texas $289M AUM 225.62% 1-Year Est. Return
PSA
Plum Street Advisors New Orleans, Louisiana $289M AUM 17.28% 1-Year Est. Return
SI
Saxon Interests Houston, Texas $290M AUM 19.97% 1-Year Est. Return
FFA
Fairfield Financial Advisors Wellesley, Massachusetts $290M AUM 15.81% 1-Year Est. Return
OCM
Orion Capital Management Coronado, California $290M AUM 17.97% 1-Year Est. Return
ODFS
O'Donnell Financial Services San Rafael, California $290M AUM 15.6% 1-Year Est. Return

Bourne Lent Asset Management's Q1 2021 Portfolio in Review

As of Q1 2021, Bourne Lent Asset Management held 63 positions worth $313M, up 3.2% from $304M the previous quarter. Its ten largest holdings account for 74% of the portfolio.

Bourne Lent Asset Management's Q1 2021 filing shows 3 new, 12 increased, 9 reduced and 2 closed positions. Its largest new stake was Invitae Corporation: 67,300 shares worth $2.57M. The largest sale was Idexx Laboratories, an estimated $752K.

By sector, the portfolio is most concentrated in Technology at 39% of assets, down from 40% a quarter earlier, followed by Healthcare and Communication Services.

  • Bourne Lent Asset Management's largest Q1 2021 buy was Invitae Corporation: 67,300 shares worth $2.57M.
  • Bourne Lent Asset Management added most to Nutrien in Q1 2021, an estimated $332K increase.
  • Bourne Lent Asset Management's biggest Q1 2021 reduction was Idexx Laboratories, cutting an estimated $752K.
  • Bourne Lent Asset Management fully exited Berkshire Hathaway Class B in Q1 2021, selling an estimated $665K.
  • Bourne Lent Asset Management's ten largest holdings make up 74% of its $313M portfolio in Q1 2021.
  • Bourne Lent Asset Management opened 3 new positions and closed 2 in Q1 2021.
  • Bourne Lent Asset Management's portfolio value rose 3.2% quarter-over-quarter to $313M.

Based on Bourne Lent Asset Management's 13F filing for Q1 2021, filed 23 Apr 2021.